David Wheeler is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust.Professor Wheeler is a clinician scientist interested in the complications of chronic kidney disease (CKD), specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated in the development and running of several large-scale clinical trials testing lipid-lowering regimens, calcimimetics, intravenous iron, sodium–glucose co-transporter 2 inhibitors and hypoxia-inducible factor stabilisers in patients with CKD.Professor Wheeler has also been involved in the development of clinical practice guidelines for several organisations, most recently for Kidney Disease: Improving Global Outcomes (KDIGO). He served as KDIGO co-Chair between 2012 and 2019. His ongoing roles include serving as the National Specialty Lead for the National Institute of Health Research Clinical Research Network and Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTs) committee. Locally he heads up the clinical research team in the Department of Renal Medicine at the Royal Free Hospital.Professor Wheeler has been involved in over 190 original research publications. He has attended numerous congresses and has been actively involved in many AstraZeneca events.
Video SeriesThe Evidence-based CKD Clinic: Changing Practice with SGLT2 Inhibition